Curis
CRIS
#10248
Rank
A$20.91 M
Marketcap
A$1.62
Share price
-6.96%
Change (1 day)
-67.15%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.55. In 2024 the company made an earnings per share (EPS) of A-$10.63 an increase over its 2023 EPS that were of A-$13.65.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-45.55%
2024A-$10.63-22.15%
2023A-$13.65-26.17%
2022A-$18.4922.3%
2021A-$15.12-25.37%
2020A-$20.26-30.93%
2019A-$29.33-2.02%
2018A-$29.94
2016A-$68.04-10%
2015A-$75.59138.1%
2014A-$31.7540%
2013A-$22.68-25%
2012A-$30.2466.67%
2011A-$18.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
A$3.60-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.13-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.54-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$5.11-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.60-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.49-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$16.99 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA